<DOC>
	<DOCNO>NCT02790281</DOCNO>
	<brief_summary>The purpose study measure IL-6 IL-6/sIL-6R complex level subject active moderate severe ulcerative colitis Crohn 's disease .</brief_summary>
	<brief_title>A Study Investigate Interleukin-6 ( IL-6 ) IL-6/Soluble IL-6 Receptor ( sIL-6R ) Complex Levels Subjects With Active Inflammatory Bowel Disease</brief_title>
	<detailed_description />
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Subjects diagnose active moderate severe ulcerative colitis ( *partial Mayo ≥ 5 ) Crohn 's disease ( Harvey &amp; Bradshaw ≥ 8 ) *partial Mayo : 9point scale excludes endoscopic component Mayo score Presence another inflammatory disease , except mild cutaneous psoriasis Concomitant gastrointestinal infection otherwise serious infection include Crohn 's disease infectious complication Treatment Infliximab , Adalimumab , Certolizumab Pegol immunemodulating biologics within 8 week prior visit Having know suspected gastrointestinal otherwise serious infection within 8 week prior visit Concomitant diagnose suspect malignant disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>